Original Research

Published on 05 Sep 2023

Using extracellular matrix derived from sugen-chronic hypoxia lung tissue to study pulmonary arterial hypertension

in Respiratory Pharmacology

Patrick A. Link
Laszlo Farkas
Rebecca L. Heise

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1192798

1,829 views

Original Research

Published on 01 Sep 2023

Use of polymyxin B with different administration methods in the critically ill patients with ventilation associated pneumonia: a single-center experience

in Respiratory Pharmacology

Rupeng Shi
Yuanyuan Fu
Yujing Gan
Danying Wu
Suming Zhou
Min Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1222044

2,136 views
3 citations

Original Research

Published on 24 Aug 2023

Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx

in Respiratory Pharmacology

Yunduan Song
Yusen Gou
Jiameng Gao
Dongxin Chen
Haibo Zhang
Wenjuan Zhao
Feng Qian
Ajing Xu
Yao Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1236469

2,476 views
1 citation

Original Research

Published on 23 Aug 2023

Obesity exacerbates influenza-induced respiratory disease via the arachidonic acid-p38 MAPK pathway

in Respiratory Pharmacology

Ravishankar Chandrasekaran
Carolyn R. Morris
Isabella M. Butzirus
Zoe F. Mark
Amit Kumar
Dhemerson Souza De Lima
Nirav Daphtary
Minara Aliyeva
Matthew E. Poynter
Vikas Anathy

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1248873

1,926 views
2 citations

Original Research

Published on 16 Aug 2023

A 20:1 synergetic mixture of cafedrine/theodrenaline accelerates particle transport velocity in murine tracheal epithelium via IP3 receptor-associated calcium release

in Respiratory Pharmacology

Götz Schmidt
Gerrit Rienas
Sabrina Müller
Fabian Edinger
Michael Sander
Christian Koch
Michael Henrich

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1155930

1,194 views

Original Research

Published on 16 Aug 2023

Comparison of the clinical efficacy and toxicity of nebulized polymyxin monotherapy and combined intravenous and nebulized polymyxin for the treatment of ventilator-associated pneumonia caused by carbapenem-resistant gram-negative bacteria: a retrospective cohort study

in Respiratory Pharmacology

Zhenping Wu
Siying Zhang
Yelin Cao
Qiyu Wang
Keyuan Sun
Xia Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1209063

1,968 views
3 citations

Original Research

Published on 16 Aug 2023

Prognostic value of oxygen inhalation therapy for simple nocturnal hypoxemia in COPD: a meta-analysis

in Respiratory Pharmacology

Ling Sun
Ya-Fei Chang
Yun-Fei Wang
Xian-Zhong Ran
Xiang-Rong Li
Quan-Xin Xie
Bin Ning

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1123945

1,391 views

Editorial

Published on 15 Aug 2023

Editorial: Case reports in respiratory pharmacology 2022

in Respiratory Pharmacology

Przemyslaw Zdziarski
Luisa Ricciardi
Roberto Paganelli

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1242273

1,548 views

Review

Published on 07 Aug 2023

Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies

in Respiratory Pharmacology

Hehua Guo
Jiazheng Sun
Siyu Zhang
Yalan Nie
Sirui Zhou
Yulan Zeng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1205948

9,557 views
12 citations

Review

Published on 03 Aug 2023

Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition

in Respiratory Pharmacology

Peng Pi
Zhipeng Zeng
Liqing Zeng
Bing Han
Xizhe Bai
Shousheng Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1218059

3,877 views
6 citations

Clinical Trial

Published on 28 Jul 2023

Long-term sedation with remimazolam besylate versus propofol in critically ill patients during invasive mechanical ventilation: a study protocol for a multicenter randomized non-inferior trial

in Respiratory Pharmacology

Xiaobo Yang
Yun Tang
Ruofei Du
Yuan Yu
Jiqian Xu
Jiancheng Zhang
Hong Liu
Xiaojing Zou
Lehao Ren
Shiying Yuan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1139872

2,473 views
1 citation

Correction

Published on 26 Jul 2023

Corrigendum: Host factor interaction networks identified by integrative bioinformatics analysis reveals therapeutic implications in COPD patients with COVID-19

in Respiratory Pharmacology

Wenjiang Zheng
Ting Wang
Peng Wu
Qian Yan
Chengxin Liu
Hui Wu
Shaofeng Zhan
Xiaohong Liu
Yong Jiang
Hongfa Zhuang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1256022

1,047 views

Review

Published on 19 Jul 2023

Recent advances in nanoparticle applications in respiratory disorders: a review

in Respiratory Pharmacology

Mohammad Ehsan Taghavizadeh Yazdi
Mohsen Qayoomian
Sima Beigoli
Mohammad Hossein Boskabady

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1059343

5,721 views
24 citations

Case Report

Published on 17 Jul 2023

Case report: Lung transplantation for treatment of paraquat intoxication: timing of transplantation

in Respiratory Pharmacology

Congcong Li
Hongfei Cai
Fanyu Meng
Fanjie Meng
Ze Tang
Ying Tang
Ying Chen
Youbin Cui
Yang Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1205689

1,997 views
3 citations

Editorial

Published on 13 Jul 2023

Editorial: Coronavirus disease (COVID-19): mechanistic basic, translational, and clinical research aimed at identification of effective preventive and therapeutic strategies

in Respiratory Pharmacology

Paolo Montuschi
Fatih M. Uckun
Alastair George Stewart
Paola Patrignani

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1247765

812 views

Original Research

Published on 13 Jul 2023

Weight increase in people with cystic fibrosis on CFTR modulator therapy is mainly due to increase in fat mass

in Respiratory Pharmacology

Marialena Mouzaki
Annie Dupuis
Julie Avolio
Katherine Griffin
Felix Ratjen
Elizabeth Tullis
Tanja Gonska

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1157459

2,799 views
5 citations

Navigation group

Articles

Using extracellular matrix derived from sugen-chronic hypoxia lung tissue to study pulmonary arterial hypertension

Use of polymyxin B with different administration methods in the critically ill patients with ventilation associated pneumonia: a single-center experience

Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx

Obesity exacerbates influenza-induced respiratory disease via the arachidonic acid-p38 MAPK pathway

A 20:1 synergetic mixture of cafedrine/theodrenaline accelerates particle transport velocity in murine tracheal epithelium via IP3 receptor-associated calcium release

Comparison of the clinical efficacy and toxicity of nebulized polymyxin monotherapy and combined intravenous and nebulized polymyxin for the treatment of ventilator-associated pneumonia caused by carbapenem-resistant gram-negative bacteria: a retrospective cohort study

Prognostic value of oxygen inhalation therapy for simple nocturnal hypoxemia in COPD: a meta-analysis

Editorial: Case reports in respiratory pharmacology 2022

Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies

Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition

Long-term sedation with remimazolam besylate versus propofol in critically ill patients during invasive mechanical ventilation: a study protocol for a multicenter randomized non-inferior trial

Corrigendum: Host factor interaction networks identified by integrative bioinformatics analysis reveals therapeutic implications in COPD patients with COVID-19

Recent advances in nanoparticle applications in respiratory disorders: a review

Case report: Lung transplantation for treatment of paraquat intoxication: timing of transplantation

Editorial: Coronavirus disease (COVID-19): mechanistic basic, translational, and clinical research aimed at identification of effective preventive and therapeutic strategies

Weight increase in people with cystic fibrosis on CFTR modulator therapy is mainly due to increase in fat mass